Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 26, 2024

BUY
$4.16 - $6.87 $143,237 - $236,547
34,432 New
34,432 $174,000
Q1 2022

May 17, 2022

SELL
$2.0 - $3.28 $20,680 - $33,915
-10,340 Closed
0 $0
Q4 2021

Feb 17, 2022

SELL
$3.14 - $5.15 $8,999 - $14,759
-2,866 Reduced 21.7%
10,340 $32,000
Q3 2021

Nov 12, 2021

BUY
$4.89 - $7.12 $64,577 - $94,026
13,206 New
13,206 $65,000
Q1 2021

May 19, 2021

SELL
$5.61 - $12.01 $82,826 - $177,315
-14,764 Closed
0 $0
Q4 2020

Feb 24, 2021

BUY
$6.99 - $9.26 $103,200 - $136,714
14,764 New
14,764 $116,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.24B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.